Preparation of two D2 partial agonists in C-14 and stable isotope labeled formsELMORE, Charles S; POWELL, Mark E; HUI XIONG et al.Journal of labelled compounds & radiopharmaceuticals. 2012, Vol 55, Num 9-10, pp 359-365, issn 0362-4803, 7 p.Article

Importance of the C28-C38 hydrophobic domain of okadaic acid for potent inhibition of protein serine-threonine phosphatases 1 and 2AFRYDRYCHOWSKI, Valerie A; URBANEK, Rebecca A; DOUNAY, Amy B et al.Bioorganic & medicinal chemistry letters (Print). 2001, Vol 11, Num 5, pp 647-649, issn 0960-894XArticle

Potent reversible inhibitors of the protein tyrosine phosphatase CD45URBANEK, Rebecca A; SUCHARD, Suzanne J; STEELMAN, Gary B et al.Journal of medicinal chemistry (Print). 2001, Vol 44, Num 11, pp 1777-1793, issn 0022-2623Article

Pyridazinoquinolinetriones as NMDA glycine-site antagonists with oral antinociceptive activity in a model of neuropathic painBARE, Thomas M; BROWN, Dean G; HERZOG, Keith J et al.Journal of medicinal chemistry (Print). 2007, Vol 50, Num 13, pp 3113-3131, issn 0022-2623, 19 p.Article

Synthesis of 7-chloro-2,3-dihydro-2-[1-(pyridinyl)alkyl]-pyridazino[4,5-b]quinoline-1,4,10(5h )-triones as NMDA glycine-site antagonistsBROWN, Dean G; URBANEK, Rebecca A; XIAO, Wenhua et al.Bioorganic & medicinal chemistry letters (Print). 2003, Vol 13, Num 20, pp 3553-3556, issn 0960-894X, 4 p.Article